Uday Chatterjee
About Uday Chatterjee
Data last updated:
Uday Chatterjee is a Director at Transcell Biosciences Private Limited (since 2022), Director at Tran-Scell Biologics Private Limited (since 2020) and Director at Shiva Eastern Information Technologies Private Limited (since 2002), and holds 3 more current directorships. The companies operate in Chemicals, Healthcare and Business Outsourcing. The 5 current companies with reported revenue have a combined latest revenue of ₹7.41 Cr; the largest is Transcell Biosciences Private Limited at ₹5.58 Cr (FY 2025). Earlier, Uday Chatterjee was a Director at Gostops Hospitality Private Limited (2021–2025) and Director at Ahammune Biosciences Private Limited (2021–2024) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Transcell Biosciences Private Limited U24290TG2022PTC162503 | Director | 11 May 2022 | 2022 | ₹5.58 Cr (FY 2025) | Active |
| Tran-Scell Biologics Private Limited U85100TG2009PTC066172 | Director | 11 May 2020 | 2009 | ₹1.44 Cr (FY 2025) | Active |
 Shiva Eastern Information Technologies Private Limited U74899DL2002PTC113947 | Director | 23 Jan 2002 | 2002 | ₹19.5 Lakh (FY 2026) | Active |
| C.T.I. Travels Private Limited U74899DL1990PTC039376 | Managing Director | 01 Mar 1990 | 1990 | ₹17.1 Lakh (FY 2026) | Active |
| Tie Dehradun Forum U85300UR2020NPL011532 | Director | 18 Nov 2022 | 2020 | ₹3.5 Lakh (FY 2025) | Active |
| Ian Beta Llp ABB-4803 | Partner | 25 Sep 2025 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gostops Hospitality Private Limited U55100DL2019PTC348075 | Director | 31 Jul 2021 | 2019 | ₹39.16 Cr (FY 2025) | Active |
 Ahammune Biosciences Private Limited U74999PN2016PTC164337 | Director | 20 Feb 2021 | 2016 | ₹1.17 Cr (FY 2025) | Active |
 Serigen Mediproducts Private Limited U74900PN2015PTC153912 | Nominee Director | 21 Jul 2023 | 2015 | ₹91.1 Lakh (FY 2025) | Active |
| Informage Realtek Private Limited U72300DL2005PTC135027 | Director | 23 Mar 2015 | 2005 | Active | |
| Informage Inca Informatics Private Limited U72200DL1997PTC090418 | Managing Director | 27 Oct 1997 | 1997 | Strike Off | |
| Inca Telecomine Private Limited U74899DL1984PTC019533 | Managing Director | 03 Oct 1990 | 1984 | Strike Off | |
| Aura Associates Private Limited U74900DL2008PTC175520 | Director | 18 Mar 2008 | 2008 | Strike Off | |
 Transcell Oncologics Private Limited U74999TG2017PTC118680 | Director | 05 Jul 2021 | 2017 | ₹4.04 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Uday Chatterjee
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Uday Chatterjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uday Chatterjee
Uday Chatterjee currently holds 6 directorships: Transcell Biosciences Private Limited (Director, since 11 May 2022, revenue ₹5.58 Cr (FY 2025)); Tran-Scell Biologics Private Limited (Director, since 11 May 2020, revenue ₹1.44 Cr (FY 2025)); Shiva Eastern Information Technologies Private Limited (Director, since 23 Jan 2002, revenue ₹19.5 Lakh (FY 2026)); C.T.I. Travels Private Limited (Managing Director, since 01 Mar 1990, revenue ₹17.1 Lakh (FY 2026)); Tie Dehradun Forum (Director, since 18 Nov 2022, revenue ₹3.5 Lakh (FY 2025)); and 1 more.
Uday Chatterjee was first appointed on 01 Mar 1990 as Managing Director at C.T.I. Travels Private Limited. The most recent appointment on record is 25 Sep 2025 at Ian Beta Llp.
The 5 current companies of Uday Chatterjee that report revenue have a combined latest revenue of ₹7.41 Cr: Transcell Biosciences Private Limited ₹5.58 Cr (FY 2025); Tran-Scell Biologics Private Limited ₹1.44 Cr (FY 2025); Shiva Eastern Information Technologies Private Limited ₹19.5 Lakh (FY 2026); C.T.I. Travels Private Limited ₹17.1 Lakh (FY 2026); Tie Dehradun Forum ₹3.5 Lakh (FY 2025).
Uday Chatterjee held 8 earlier board appointments: Gostops Hospitality Private Limited (Director, 31 Jul 2021 to 24 Jul 2025); Ahammune Biosciences Private Limited (Director, 20 Feb 2021 to 28 Sep 2024); Serigen Mediproducts Private Limited (Nominee Director, 21 Jul 2023 to 29 Aug 2024); Informage Realtek Private Limited (Director, 23 Mar 2015 to 08 May 2020); Informage Inca Informatics Private Limited (Managing Director, from 27 Oct 1997); and 3 more.
The current boards of Uday Chatterjee's companies include Subhadra Dravida (Transcell Biosciences Private Limited), Asif Wahidul Hasan (Tran-Scell Biologics Private Limited), Vinayender Tulla (Tran-Scell Biologics Private Limited), Retu Chatterjee Mehra (Shiva Eastern Information Technologies Private Limited), Pramod Kalani (Tie Dehradun Forum), Sanjay Agarwal (Tie Dehradun Forum), among others.